世界の薬物誘発性聴器毒性治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Drug Induced Ototoxicity Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4158
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、薬物誘発性聴器毒性治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（代替療法、医薬品、補聴器、人工内耳、福祉機器（ALD））、用途別市場規模（蝸牛薬原因聴器毒性、前庭薬原因聴器毒性）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・薬物誘発性聴器毒性治療の市場動向
・企業の競争状況、市場シェア
・薬物誘発性聴器毒性治療の種類別市場規模と予測2016-2027（代替療法、医薬品、補聴器、人工内耳、福祉機器（ALD））
・薬物誘発性聴器毒性治療の用途別市場規模と予測2016-2027（蝸牛薬原因聴器毒性、前庭薬原因聴器毒性）
・薬物誘発性聴器毒性治療の北米市場規模2016-2027（アメリカ、カナダ）
・薬物誘発性聴器毒性治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・薬物誘発性聴器毒性治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・薬物誘発性聴器毒性治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・薬物誘発性聴器毒性治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Advanced Bionics、Pfizer、Otonomy、Eli Lilly and Company、Sound Pharmaceuticals、WellSpring Pharmaceutical Corporation、Hoffmann-La Roche、Teva Pharmaceuticals、GlaxoSmithKline、Sonova Holding）
・結論

Drug induced ototoxicity is defined as damage to the Cochlea and vestibule caused by the use or exposure to certain therapeutic or chemical drugs Common OTOTOXIC drugs are: aminoglycoside antibiotics, salicylic acid, quinine and loop diuretics, anti-tumor chemotherapy drugs.

Market Analysis and Insights: Global Drug Induced Ototoxicity Treatment Market
The global Drug Induced Ototoxicity Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Induced Ototoxicity Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Induced Ototoxicity Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Induced Ototoxicity Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Induced Ototoxicity Treatment market.

Global Drug Induced Ototoxicity Treatment Scope and Market Size
Drug Induced Ototoxicity Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Induced Ototoxicity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Alternative Therapies
Medications
Hearing Aids
Cochlear Implants
Assistive Listening Devices (ALD’s)

Segment by Application
Cochlear Drug-Induced Ototoxicity
Vestibular Drug-Induced Ototoxicity

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Advanced Bionics
Pfizer
Otonomy
Eli Lilly and Company
Sound Pharmaceuticals
WellSpring Pharmaceutical Corporation
Hoffmann-La Roche
Teva Pharmaceuticals
GlaxoSmithKline
Sonova Holding

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Induced Ototoxicity Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Alternative Therapies
1.2.3 Medications
1.2.4 Hearing Aids
1.2.5 Cochlear Implants
1.2.6 Assistive Listening Devices (ALD’s)
1.3 Market by Application
1.3.1 Global Drug Induced Ototoxicity Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cochlear Drug-Induced Ototoxicity
1.3.3 Vestibular Drug-Induced Ototoxicity
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drug Induced Ototoxicity Treatment Market Perspective (2016-2027)
2.2 Drug Induced Ototoxicity Treatment Growth Trends by Regions
2.2.1 Drug Induced Ototoxicity Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Induced Ototoxicity Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Drug Induced Ototoxicity Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Drug Induced Ototoxicity Treatment Industry Dynamic
2.3.1 Drug Induced Ototoxicity Treatment Market Trends
2.3.2 Drug Induced Ototoxicity Treatment Market Drivers
2.3.3 Drug Induced Ototoxicity Treatment Market Challenges
2.3.4 Drug Induced Ototoxicity Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drug Induced Ototoxicity Treatment Players by Revenue
3.1.1 Global Top Drug Induced Ototoxicity Treatment Players by Revenue (2016-2021)
3.1.2 Global Drug Induced Ototoxicity Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Drug Induced Ototoxicity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Induced Ototoxicity Treatment Revenue
3.4 Global Drug Induced Ototoxicity Treatment Market Concentration Ratio
3.4.1 Global Drug Induced Ototoxicity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Induced Ototoxicity Treatment Revenue in 2020
3.5 Drug Induced Ototoxicity Treatment Key Players Head office and Area Served
3.6 Key Players Drug Induced Ototoxicity Treatment Product Solution and Service
3.7 Date of Enter into Drug Induced Ototoxicity Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Induced Ototoxicity Treatment Breakdown Data by Type
4.1 Global Drug Induced Ototoxicity Treatment Historic Market Size by Type (2016-2021)
4.2 Global Drug Induced Ototoxicity Treatment Forecasted Market Size by Type (2022-2027)

5 Drug Induced Ototoxicity Treatment Breakdown Data by Application
5.1 Global Drug Induced Ototoxicity Treatment Historic Market Size by Application (2016-2021)
5.2 Global Drug Induced Ototoxicity Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drug Induced Ototoxicity Treatment Market Size (2016-2027)
6.2 North America Drug Induced Ototoxicity Treatment Market Size by Type
6.2.1 North America Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021)
6.2.2 North America Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027)
6.2.3 North America Drug Induced Ototoxicity Treatment Market Size by Type (2016-2027)
6.3 North America Drug Induced Ototoxicity Treatment Market Size by Application
6.3.1 North America Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021)
6.3.2 North America Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027)
6.3.3 North America Drug Induced Ototoxicity Treatment Market Size by Application (2016-2027)
6.4 North America Drug Induced Ototoxicity Treatment Market Size by Country
6.4.1 North America Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021)
6.4.2 North America Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Drug Induced Ototoxicity Treatment Market Size (2016-2027)
7.2 Europe Drug Induced Ototoxicity Treatment Market Size by Type
7.2.1 Europe Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021)
7.2.2 Europe Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027)
7.2.3 Europe Drug Induced Ototoxicity Treatment Market Size by Type (2016-2027)
7.3 Europe Drug Induced Ototoxicity Treatment Market Size by Application
7.3.1 Europe Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021)
7.3.2 Europe Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027)
7.3.3 Europe Drug Induced Ototoxicity Treatment Market Size by Application (2016-2027)
7.4 Europe Drug Induced Ototoxicity Treatment Market Size by Country
7.4.1 Europe Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021)
7.4.2 Europe Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size (2016-2027)
8.2 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Type
8.2.1 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Application
8.3.1 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Region
8.4.1 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drug Induced Ototoxicity Treatment Market Size (2016-2027)
9.2 Latin America Drug Induced Ototoxicity Treatment Market Size by Type
9.2.1 Latin America Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Drug Induced Ototoxicity Treatment Market Size by Type (2016-2027)
9.3 Latin America Drug Induced Ototoxicity Treatment Market Size by Application
9.3.1 Latin America Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Drug Induced Ototoxicity Treatment Market Size by Application (2016-2027)
9.4 Latin America Drug Induced Ototoxicity Treatment Market Size by Country
9.4.1 Latin America Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size (2016-2027)
10.2 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Type
10.2.1 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Application
10.3.1 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Country
10.4.1 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Advanced Bionics
11.1.1 Advanced Bionics Company Details
11.1.2 Advanced Bionics Business Overview
11.1.3 Advanced Bionics Drug Induced Ototoxicity Treatment Introduction
11.1.4 Advanced Bionics Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.1.5 Advanced Bionics Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drug Induced Ototoxicity Treatment Introduction
11.2.4 Pfizer Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Otonomy
11.3.1 Otonomy Company Details
11.3.2 Otonomy Business Overview
11.3.3 Otonomy Drug Induced Ototoxicity Treatment Introduction
11.3.4 Otonomy Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.3.5 Otonomy Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Drug Induced Ototoxicity Treatment Introduction
11.4.4 Eli Lilly and Company Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.4.5 Eli Lilly and Company Recent Development
11.5 Sound Pharmaceuticals
11.5.1 Sound Pharmaceuticals Company Details
11.5.2 Sound Pharmaceuticals Business Overview
11.5.3 Sound Pharmaceuticals Drug Induced Ototoxicity Treatment Introduction
11.5.4 Sound Pharmaceuticals Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.5.5 Sound Pharmaceuticals Recent Development
11.6 WellSpring Pharmaceutical Corporation
11.6.1 WellSpring Pharmaceutical Corporation Company Details
11.6.2 WellSpring Pharmaceutical Corporation Business Overview
11.6.3 WellSpring Pharmaceutical Corporation Drug Induced Ototoxicity Treatment Introduction
11.6.4 WellSpring Pharmaceutical Corporation Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.6.5 WellSpring Pharmaceutical Corporation Recent Development
11.7 Hoffmann-La Roche
11.7.1 Hoffmann-La Roche Company Details
11.7.2 Hoffmann-La Roche Business Overview
11.7.3 Hoffmann-La Roche Drug Induced Ototoxicity Treatment Introduction
11.7.4 Hoffmann-La Roche Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.7.5 Hoffmann-La Roche Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Drug Induced Ototoxicity Treatment Introduction
11.8.4 Teva Pharmaceuticals Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Drug Induced Ototoxicity Treatment Introduction
11.9.4 GlaxoSmithKline Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.9.5 GlaxoSmithKline Recent Development
11.10 Sonova Holding
11.10.1 Sonova Holding Company Details
11.10.2 Sonova Holding Business Overview
11.10.3 Sonova Holding Drug Induced Ototoxicity Treatment Introduction
11.10.4 Sonova Holding Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021)
11.10.5 Sonova Holding Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Drug Induced Ototoxicity Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Alternative Therapies
Table 3. Key Players of Medications
Table 4. Key Players of Hearing Aids
Table 5. Key Players of Cochlear Implants
Table 6. Key Players of Assistive Listening Devices (ALD’s)
Table 7. Global Drug Induced Ototoxicity Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Drug Induced Ototoxicity Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Drug Induced Ototoxicity Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Drug Induced Ototoxicity Treatment Market Share by Regions (2016-2021)
Table 11. Global Drug Induced Ototoxicity Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Drug Induced Ototoxicity Treatment Market Share by Regions (2022-2027)
Table 13. Drug Induced Ototoxicity Treatment Market Trends
Table 14. Drug Induced Ototoxicity Treatment Market Drivers
Table 15. Drug Induced Ototoxicity Treatment Market Challenges
Table 16. Drug Induced Ototoxicity Treatment Market Restraints
Table 17. Global Drug Induced Ototoxicity Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Drug Induced Ototoxicity Treatment Market Share by Players (2016-2021)
Table 19. Global Top Drug Induced Ototoxicity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Induced Ototoxicity Treatment as of 2020)
Table 20. Ranking of Global Top Drug Induced Ototoxicity Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Drug Induced Ototoxicity Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug Induced Ototoxicity Treatment Product Solution and Service
Table 24. Date of Enter into Drug Induced Ototoxicity Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Drug Induced Ototoxicity Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Drug Induced Ototoxicity Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Drug Induced Ototoxicity Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Drug Induced Ototoxicity Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Drug Induced Ototoxicity Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Drug Induced Ototoxicity Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Drug Induced Ototoxicity Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Drug Induced Ototoxicity Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Drug Induced Ototoxicity Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Advanced Bionics Company Details
Table 65. Advanced Bionics Business Overview
Table 66. Advanced Bionics Drug Induced Ototoxicity Treatment Product
Table 67. Advanced Bionics Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 68. Advanced Bionics Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Drug Induced Ototoxicity Treatment Product
Table 72. Pfizer Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Otonomy Company Details
Table 75. Otonomy Business Overview
Table 76. Otonomy Drug Induced Ototoxicity Treatment Product
Table 77. Otonomy Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 78. Otonomy Recent Development
Table 79. Eli Lilly and Company Company Details
Table 80. Eli Lilly and Company Business Overview
Table 81. Eli Lilly and Company Drug Induced Ototoxicity Treatment Product
Table 82. Eli Lilly and Company Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 83. Eli Lilly and Company Recent Development
Table 84. Sound Pharmaceuticals Company Details
Table 85. Sound Pharmaceuticals Business Overview
Table 86. Sound Pharmaceuticals Drug Induced Ototoxicity Treatment Product
Table 87. Sound Pharmaceuticals Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 88. Sound Pharmaceuticals Recent Development
Table 89. WellSpring Pharmaceutical Corporation Company Details
Table 90. WellSpring Pharmaceutical Corporation Business Overview
Table 91. WellSpring Pharmaceutical Corporation Drug Induced Ototoxicity Treatment Product
Table 92. WellSpring Pharmaceutical Corporation Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 93. WellSpring Pharmaceutical Corporation Recent Development
Table 94. Hoffmann-La Roche Company Details
Table 95. Hoffmann-La Roche Business Overview
Table 96. Hoffmann-La Roche Drug Induced Ototoxicity Treatment Product
Table 97. Hoffmann-La Roche Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 98. Hoffmann-La Roche Recent Development
Table 99. Teva Pharmaceuticals Company Details
Table 100. Teva Pharmaceuticals Business Overview
Table 101. Teva Pharmaceuticals Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 102. Teva Pharmaceuticals Recent Development
Table 103. GlaxoSmithKline Company Details
Table 104. GlaxoSmithKline Business Overview
Table 105. GlaxoSmithKline Drug Induced Ototoxicity Treatment Product
Table 106. GlaxoSmithKline Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 107. GlaxoSmithKline Recent Development
Table 108. Sonova Holding Company Details
Table 109. Sonova Holding Business Overview
Table 110. Sonova Holding Drug Induced Ototoxicity Treatment Product
Table 111. Sonova Holding Revenue in Drug Induced Ototoxicity Treatment Business (2016-2021) & (US$ Million)
Table 112. Sonova Holding Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Induced Ototoxicity Treatment Market Share by Type: 2020 VS 2027
Figure 2. Alternative Therapies Features
Figure 3. Medications Features
Figure 4. Hearing Aids Features
Figure 5. Cochlear Implants Features
Figure 6. Assistive Listening Devices (ALD’s) Features
Figure 7. Global Drug Induced Ototoxicity Treatment Market Share by Application: 2020 VS 2027
Figure 8. Cochlear Drug-Induced Ototoxicity Case Studies
Figure 9. Vestibular Drug-Induced Ototoxicity Case Studies
Figure 10. Drug Induced Ototoxicity Treatment Report Years Considered
Figure 11. Global Drug Induced Ototoxicity Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Drug Induced Ototoxicity Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drug Induced Ototoxicity Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Drug Induced Ototoxicity Treatment Market Share by Regions (2022-2027)
Figure 15. Global Drug Induced Ototoxicity Treatment Market Share by Players in 2020
Figure 16. Global Top Drug Induced Ototoxicity Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Induced Ototoxicity Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Drug Induced Ototoxicity Treatment Revenue in 2020
Figure 18. Global Drug Induced Ototoxicity Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Drug Induced Ototoxicity Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Drug Induced Ototoxicity Treatment Market Share by Type (2016-2027)
Figure 22. North America Drug Induced Ototoxicity Treatment Market Share by Application (2016-2027)
Figure 23. North America Drug Induced Ototoxicity Treatment Market Share by Country (2016-2027)
Figure 24. United States Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Drug Induced Ototoxicity Treatment Market Share by Type (2016-2027)
Figure 28. Europe Drug Induced Ototoxicity Treatment Market Share by Application (2016-2027)
Figure 29. Europe Drug Induced Ototoxicity Treatment Market Share by Country (2016-2027)
Figure 30. Germany Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Drug Induced Ototoxicity Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Drug Induced Ototoxicity Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Drug Induced Ototoxicity Treatment Market Share by Region (2016-2027)
Figure 40. China Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Drug Induced Ototoxicity Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Drug Induced Ototoxicity Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Drug Induced Ototoxicity Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Drug Induced Ototoxicity Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Drug Induced Ototoxicity Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Drug Induced Ototoxicity Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Drug Induced Ototoxicity Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Advanced Bionics Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 61. Otonomy Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 62. Eli Lilly and Company Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 63. Sound Pharmaceuticals Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 64. WellSpring Pharmaceutical Corporation Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 65. Hoffmann-La Roche Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 68. Sonova Holding Revenue Growth Rate in Drug Induced Ototoxicity Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界のオピオイド誘発性副作用治療市場規模・現状・予測（2021年-2027年）

Global Opioid Induced Side Effects Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5911 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、オピオイド誘発性副作用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リスペリドン、メチルフェニデート、セチリジン、その他）、用途別市場規模（薬物過剰摂取治療、疼痛治療、その他）、主要地域別市場規...

世界のヘパリン起因性血小板減少症 (HIT) 治療市場規模・現状・予測（2021年-2027年）

Global Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4300 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ヘパリン起因性血小板減少症 (HIT) 治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、診断センター、専門医クリニック、病院薬局）、主要地域別市場規模（北米、ア...

世界の化学療法による悪心＆嘔吐治療市場規模・現状・予測（2021年-2027年）

Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5654 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、化学療法による悪心＆嘔吐治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アロキシ（パロノセトロン）、キトリル（グラニセトロン）、エメンド（アプレピタント）、その他）、用途別市場規模（急性悪心＆嘔吐...

世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3999 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、化学療法誘発性血小板減少症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の非薬物式うつ病治療市場規模・現状・予測（2021年-2027年）

Global Drug Free Depression Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4157 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非薬物式うつ病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（認知行動療法、経頭蓋磁気刺激法、鍼治療、誘導イメージ療法、その他）、用途別市場規模（病院、専門クリニック、外来外科センター、診断センタ...

世界の風邪薬市場規模・現状・予測（2021年-2027年）

Global Cold Treatment Drug Market Size, Status and Forecast 2021-2027
QFJ1-4033 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、風邪薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（咳止め薬、呼吸器感染症、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のヘモグロビン症用治療薬市場規模・現状・予測（2021年-2027年）

Global Hemoglobinopathy Treatment Drug Market Size, Status and Forecast 2021-2027
QFJ1-4298 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、ヘモグロビン症用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、抗生物質、ACE阻害剤、ヒドロキシウレア、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規...

世界の好中球減少症生物学的製剤治療市場規模・現状・予測（2021年-2027年）

Global Neutropenia Biologic Drug Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4576 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、好中球減少症生物学的製剤治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フィルグラスチム、ペグフィルグラスチム、レノグラスチム、リペグフィルグラスチム、サルグラモスチム）、用途別市場規模（小売薬局...

世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4533 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のオピオイド誘発性副作用治療市場規模・現状・予測（2021年-2027年） Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body a…
世界のヘパリン起因性血小板減少症 (HIT) 治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heparin-Induced Thrombocytopenia (HIT) Treatment Market The global Heparin-Induced Thrombocytopenia (HIT) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard ac…
化学療法による好中球減少薬のグローバル市場調査 2019年 The global Chemotherapy Induced Neutropenia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chemotherapy Induced Neutropenia Drug volume and value at global level, regional level and company le…
世界の化学療法による悪心＆嘔吐治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chemotheraphy-induced Nausea and Vomitting Treatment Market The global Chemotheraphy-induced Nausea and Vomitting Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-sta…
化学療法誘発性末梢神経障害治療のグローバル市場2021 CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemother…